Genomic characterization of three urinary bladder cancer cell lines: understanding genomic types of urinary bladder cancer

Meloxicam in the treatment of in vitro and in vivo models of urinary bladder cancer

(2013) Regina Arantes-Rodrigues et al.   BIOMEDICINE & PHARMACOTHERAPY

Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines

(2013) Panagiotis K Karkoulis et al.   Cancer Cell International

Genome-wide methylation profiling and the PI3K-AKT pathway analysis associated with smoking in urothelial cell carcinoma

(2013) Mariana Brait et al.   CELL CYCLE

miR-708 promotes the development of bladder carcinoma via direct repression of Caspase-2

(2013) Tao Song et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Over-expression of LRIG3 suppresses growth and invasion of bladder cancer cells

(2013) Yong Qi et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

Expression Microarray Meta-Analysis Identifies Genes Associated with Ras/MAPK and Related Pathways in Progression of Muscle-Invasive Bladder Transition Cell Carcinoma

(2013) Jonathan A. Ewald et al.   PLoS One

Identification of Nine Genomic Regions of Amplification in Urothelial Carcinoma, Correlation with Stage, and Potential Prognostic and Therapeutic Value

(2013) Yvonne Chekaluk et al.   PLoS One

ALKBH2, a novel AlkB homologue, contributes to human bladder cancer progression by regulating MUC1 expression

(2012) Tomomi Fujii et al.   CANCER SCIENCE

Everolimus Enhances Gemcitabine-Induced Cytotoxicity in Bladder-Cancer Cell Lines

(2012) Rosário Pinto-Leite et al.   JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES

Downregulated MEG3 activates autophagy and increases cell proliferation in bladder cancer

(2012) Liang Ying et al.   Molecular BioSystems

Cell-line authentication: End the scandal of false cell lines

(2012) John R. Masters   NATURE

Integrated Genomic and Gene Expression Profiling Identifies Two Major Genomic Circuits in Urothelial Carcinoma

(2012) David Lindgren et al.   PLoS One

cAMP response element modulator   controls IL2 and IL17A expression during CD4 lineage commitment and subset distribution in lupus

(2012) C. M. Hedrich et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The bladder cancer genome; chromosomal changes as prognostic makers, opportunities, and obstacles

(2012) Mattias Höglund   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Chemotherapy in advanced bladder cancer: current status and future

(2011) Nabil Ismaili et al.   Journal of Hematology & Oncology

Molecular biomarkers in urothelial carcinoma of the bladder: are we there yet?

(2011) George J. Netto   Nature Reviews Urology

canSAR: an integrated cancer public translational research and drug discovery resource

(2011) Mark D. Halling-Brown et al.   NUCLEIC ACIDS RESEARCH

KEGG for integration and interpretation of large-scale molecular data sets

(2011) M. Kanehisa et al.   NUCLEIC ACIDS RESEARCH

Selective Genomic Copy Number Imbalances and Probability of Recurrence in Early-Stage Breast Cancer

(2011) Patricia A. Thompson et al.   PLoS One

Global gene expression changes in human urothelial cells exposed to low-level monomethylarsonous acid

(2011) Matthew Medeiros et al.   TOXICOLOGY

In vivo and in vitro effects of RAD001 on bladder cancer

(2011) Carmen Vasconcelos-Nóbrega et al.   UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS

Pro-tumorigenic Effects of miR-31 Loss in Mesothelioma

(2010) Sergey V. Ivanov et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells

(2010) Glenda N. da Silva et al.   MOLECULAR BIOLOGY REPORTS

FGFR3, HRAS, KRAS, NRAS and PIK3CA Mutations in Bladder Cancer and Their Potential as Biomarkers for Surveillance and Therapy

(2010) Lucie C. Kompier et al.   PLoS One

RETRACTED: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis

(2009) Scott Valastyan et al.   CELL

The Use of Short Tandem Repeat Profiling to Characterize Human Bladder Cancer Cell Lines

(2009) Edmund Chiong et al.   JOURNAL OF UROLOGY

Cytoplasmic functions of the tumour suppressor p53

(2009) Douglas R. Green et al.   NATURE

COSMIC (the Catalogue of Somatic Mutations in Cancer): a resource to investigate acquired mutations in human cancer

(2009) Simon A. Forbes et al.   NUCLEIC ACIDS RESEARCH

A wiki for the life sciences where authorship matters

(2008) Robert Hoffmann   NATURE GENETICS

Increased nucleotide polymorphic changes in the 5′-untranslated region of δ-catenin (CTNND2) gene in prostate cancer

(2008) T Wang et al.   ONCOGENE

Chromosomal and proteome analysis of a new T24-based cell line model for aggressive bladder cancer

(2008) Manousos Makridakis et al.   PROTEOMICS

Harnblasenkarzinomzelllinien als Modellsysteme zur Pathobiologie des Harnblasenkarzinoms

(2008) J. Hatina et al.   UROLOGE